Related Experiment Video
Updated: Mar 26, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
New-onset Atrial Fibrillation is Associated With Polycystic Kidney Disease: A Nationwide Population-based Cohort
Tung-Min Yu1, Ya-Wen Chuang, Mei-Ching Yu
1From the Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University (T-MY, C-HK); Division of Nephrology, Taichung Veterans General Hospital, Taichung (T-MY, Y-WC); Department of Pediatric Nephrology, Chang Gung Children's Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan (M-CY); Management Office for Health Data, China Medical University Hospital, Taichung (C-LL); Neurology and Medical Intensive Care Unit, Changhua Christian Hospital, Changhua (C-CC); College of Medicine, China Medical University (C-LL); and Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan (C-HK).
Insights
Patients with polycystic kidney disease (PKD) have a significantly higher risk of developing atrial fibrillation (AF). This association strengthens with increased cardiovascular risk factors, warranting vigilance and early treatment in PKD patients.
Area of Science:
- Nephrology
- Cardiology
- Epidemiology
Background:
- Cardiovascular complications are a leading cause of death in Polycystic Kidney Disease (PKD).
- Atrial fibrillation (AF) is a common cardiovascular complication with significant morbidity and mortality.
- The relationship between PKD and AF risk requires further investigation.
Purpose of the Study:
- To investigate the association between Polycystic Kidney Disease (PKD) and the risk of developing atrial fibrillation (AF).
- To quantify the incidence and hazard ratio of AF in patients with PKD compared to controls.
- To explore the impact of combined risk factors on AF incidence in PKD patients.
Main Methods:
- A nationwide population-based cohort study utilizing inpatient claims data.
- Inclusion of 7203 patients diagnosed with PKD (1998-2010) without prior AF history.
- Selection of 28,739 matched controls without PKD, frequency-matched by age, sex, and comorbidity.
Main Results:
- The incidence of AF was 7.08 per 1000 person-years in the PKD cohort versus 4.98 in the control cohort.
- Patients with PKD had a 1.31-fold increased risk of AF (aHR=1.31, 95% CI=1.14-1.51).
- AF risk escalated significantly with increasing numbers of cardiovascular risk factors in PKD patients, reaching an aHR of 3.64 for >5 risk factors.
Conclusions:
- Polycystic Kidney Disease (PKD) is independently associated with an increased risk of atrial fibrillation (AF).
- The risk of AF in PKD patients is amplified by the presence of multiple cardiovascular risk factors.
- Clinical vigilance for irregular heart rhythms and early prophylactic therapy are recommended for PKD patients, especially those with comorbidities.
Abstract:
Cardiovascular complications remain the major problems contributing to morbidity and mortality in patients with polycystic kidney disease (PKD). Therefore, the authors hypothesized that atrial fibrillation (AF) is closely associated with PKD. The authors conducted a nationwide population-based cohort study to investigate the risk of AF in patients with PKD. Using data from inpatient claims, the authors enrolled 7203 patients aged over 20 years who were diagnosed with PKD from 1998 to 2010 with no history of AF as the PKD cohort. They randomly selected 28,739 people without PKD as controls and frequency matched them with patients with PKD according to their age, sex, and baseline comorbidity. In total, 247 PKD patients were diagnosed with AF, representing an incidence of 7.08 per 1000 person-years, whereas 807 cases of AF occurred in the comparison cohort, yielding an incidence of 4.98 per 1000 person-y, with an adjusted HR (aHR) of 1.31 (95% CI = 1.14-1.51). The risk of AF increased from an aHR of 1.59 (95% CI = 1.15-2.21) to 3.64 (95% CI = 1.93-6.85) when the number of risk factors increased from 1 to more than 5 in comparison with patients without risk factors. A remarkably high incidence rate and risk was observed in patients with PKD when multiple risk factors were combined. A high index of suspicion should be maintained when examining PKD patients with irregular betas. Early prophylactic therapy is warranted in these patients.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Nephrons
Chronic Kidney Disease I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

